Diseases, Conditions, Syndromes

Shorter tuberculosis treatment not a successful alternative

A clinical drug trial conducted in five Sub-Sahara African countries shows that a shortened (four month) treatment for tuberculosis (TB) is well tolerated and may work well in subsets of TB patients, but overall could not ...

Medical research

Peptide derived from fungi kills TB bacteria

The discovery of the peptide as a possible future antibiotic was made by researchers who screened different antimicrobial peptides' ability to prevent the growth of Mycobacterium tuberculosis. The peptide they found comes ...

Health informatics

Artificial intelligence could reduce barriers to tuberculosis care

A new study led by faculty at the University of Georgia demonstrates the potential of using artificial intelligence to transform tuberculosis (TB) treatment in low-resource communities. And while the study focused on TB patients, ...

Diseases, Conditions, Syndromes

S.Africa conducts trials for shorter TB treatment

South African researchers said Friday they were conducting medical trials to shorten the duration of tuberculosis treatment to make it easier for patients to complete the full regimen.

Diseases, Conditions, Syndromes

India wages hi-tech war on ancient TB scourge

(AP)—Shammo Khan walks into a dusty courtyard that reeks of garbage, searching for the fingerprint of a man exhausted by HIV, drug withdrawal and the tuberculosis lesions hijacking his lungs.

page 4 from 8